TOPLINE:
Nearly 12% of individuals using preexposure prophylaxis (PrEP) for HIV prevention, were diagnosed with alcohol use disorder (AUD) within 6 months of initiating PrEP, whereas nearly 3% were diagnosed before initiation. Fewer than 9% of those diagnosed received any US Food and Drug Administration (FDA)–approved medication for AUD.
METHODOLOGY:
- Researchers carried out a retrospective cohort study using data from the US health claims to assess the prevalence of AUD among individuals using PrEP for the prevention of HIV.
- They included 43,913 individuals (mean age, 35.8 years; 90.1% men) who received a PrEP prescription between January 2014 and December 2021.
- The study outcome was an AUD diagnosis within 6 months before or after PrEP initiation, identified using suitable…